• What hematologic toxicities occur after venetoclax + azacitidine in MDS and how can they be managed?

  • Jun 24 2021
  • Duración: 3 m
  • Podcast

What hematologic toxicities occur after venetoclax + azacitidine in MDS and how can they be managed?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • During the EHA2021 Virtual Congress, the MDS Hub spoke with Vinod Pullarkat, City of Hope Comprehensive Cancer Center, Duarte, US. We asked, What hematologic toxicities occur after venetoclax + azacitidine in MDS and how can they be managed?


    Pullarkat discusses the hematoloigc toxicities associated with venetoclax and azacitidine, which are largely related to cytopenias. He explains that the key to managing these toxicities is close monitoring of patients and providing transfusion support as needed. Finally, he mentions that a high percentage of patients will require dose modifications.



    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre What hematologic toxicities occur after venetoclax + azacitidine in MDS and how can they be managed?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles